Edge Wealth Management’s TherapeuticsMD TXMD Stock Holding History

Edge Wealth Management’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-17	Closed	-$1K	–	425
2021 Q4	$1K	Hold	17	–	–	﹤0.01%	492
2021 Q3	$1K	Hold	17	–	–	﹤0.01%	510
2021 Q2	$1K	Hold	17	–	–	﹤0.01%	420
2021 Q1	$1K	Hold	17	–	–	﹤0.01%	416
2020 Q4	$1K	Buy	+17	New	+$1.16K	﹤0.01%	364
2020 Q1	–	Sell	-16	Closed	-$2K	–	680
2019 Q4	$2K	Hold	16	–	–	﹤0.01%	542
2019 Q3	$2K	Hold	16	–	–	﹤0.01%	534
2019 Q2	$2K	Hold	16	–	–	﹤0.01%	542
2019 Q1	$4K	Hold	16	–	–	﹤0.01%	489
2018 Q4	$3K	Hold	16	–	–	﹤0.01%	514
2018 Q3	$5K	Hold	16	–	–	﹤0.01%	509
2018 Q2	$5K	Hold	16	–	–	﹤0.01%	493
2018 Q1	$4K	Sell	16 -400	-96%	-$112K	﹤0.01%	473
2017 Q4	$125K	Buy	416 +400	+2,500%	+$111K	0.04%	159
2017 Q3	$4K	Buy	+16	New	+$4.63K	﹤0.01%	457

Other funds holding TXMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Edge Wealth Management's TXMD Position: Q1 2022 in Review

Edge Wealth Management sold out of TherapeuticsMD (TXMD) in Q1 2022, closing a stake of 17 shares — an estimated $1K sold.

Edge Wealth Management first reported a position in TXMD in Q3 2017 and held it in 15 quarters. The position peaked at $125K in Q4 2017. 124 funds tracked by Wall St. Rank hold TXMD as of Q1 2022.

Edge Wealth Management reported no remaining TherapeuticsMD position as of Q1 2022 after selling out during the quarter.
Edge Wealth Management sold 17 TherapeuticsMD shares in Q1 2022, an estimated $1K.
Edge Wealth Management first reported a position in TherapeuticsMD in Q3 2017 and held it in 15 quarters.
Edge Wealth Management's TherapeuticsMD position peaked at $125K in Q4 2017.
124 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2022.

Based on Edge Wealth Management's 13F filing for Q1 2022, filed 14 Apr 2022.